Research Article
Analysis of CBP (CREBBP) gene deletions in Rubinstein‐Taybi syndrome patients using real‐time quantitative PCR*
*
Communicated by Paolo M. Fortina
Abstract
Rubinstein‐Taybi syndrome (RTS) is a well‐defined syndrome characterized by facial abnormalities, broad thumbs, broad big toes, and growth and mental retardation as the main clinical features. RTS was shown to be associated with disruption of the CREB–binding protein gene CBP (CREBBP), either by gross chromosomal rearrangements or by point mutations. Translocations and inversions involving chromosome band 16p13.3 form the minority of CBP mutations, whereas microdeletions occur more frequently (about 10%). Most deletion studies in RTS are performed by FISH analysis, and five cosmids must be used to cover the whole of the CBP gene, which spreads over 150 kb. Here we report the design of gene dosage assays by real‐time quantitative PCR that are targeted on three exons located respectively at the 5′ end (exon 2), in the middle (exon 12), and at the 3′ end (exon 30) of the CBP gene. This technique proved to be efficient and powerful in finding deletions and complementary to the other available techniques, since it allowed us to identify deletions at the 3′ end of the gene that had been missed by FISH analysis, and to refine some deletion breakpoints. Our results therefore suggest that real‐time quantitative PCR is a useful technique to be included in the deletion search in RTS patients. Hum Mutat 23:278–284, 2004. © 2004 Wiley‐Liss, Inc.
Citing Literature
Number of times cited: 27
- Kunka Kamenarova, Emil Simeonov, Reni Tzveova, Daniela Dacheva, Marin Penkov, Ivo Kremensky, Penka Perenovska, Vanio Mitev and Radka Kaneva, Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report, Human Pathology, 47, 1, (144), (2016).
- Daniela Rusconi, Gloria Negri, Patrizia Colapietro, Chiara Picinelli, Donatella Milani, Silvia Spena, Cinzia Magnani, Margherita Cirillo Silengo, Lorena Sorasio, Vaclava Curtisova, Maria Luigia Cavaliere, Paolo Prontera, Gabriela Stangoni, Giovanni Battista Ferrero, Elisa Biamino, Rita Fischetto, Maria Piccione, Paolo Gasparini, Leonardo Salviati, Angelo Selicorni, Palma Finelli, Lidia Larizza and Cristina Gervasini, Characterization of 14 novel deletions underlying Rubinstein–Taybi syndrome: an update of the CREBBP deletion repertoire, Human Genetics, 134, 6, (613), (2015).
- Elizabeth Park, Yunha Kim, Hyun Ryu, Neil W. Kowall, Junghee Lee and Hoon Ryu, Epigenetic Mechanisms of Rubinstein–Taybi Syndrome, NeuroMolecular Medicine, 16, 1, (16), (2014).
- Mariam Tajir, Patricia Fergelot, Guenaelle Lancelot, Siham Chafai Elalaoui, Benoit Arveiler, Didier Lacombe and Abdelaziz Sefiani, Germline mosaicism in Rubinstein–Taybi syndrome, Gene, 518, 2, (476), (2013).
- Md A Mohd Fadley, Azli Ismail, Thong Meow Keong, Narazah Mohd Yusoff and Zubaidah Zakaria, Chromosomal 16p microdeletion in Rubinstein-Taybi syndrome detected by oligonucleotide-based array comparative genomic hybridization: a case report, Journal of Medical Case Reports, 6, 1, (2012).
- Michael J. Powell, Vladimir M. Popov, Xiang Wang, Steven B. McMahon, Alexander Mazo and Richard G. Pestell, The Role of Epigenetic Modifications in Cancer, Cancer Epigenetics, (113-144), (2011).
- FARAH R. ZAHIR and CAROLYN J. BROWN, Epigenetic Impacts on Neurodevelopment: Pathophysiological Mechanisms and Genetic Modes of Action, Pediatric Research, 10.1203/PDR.0b013e318213565e, 69, 5 Part 2, (92R-100R), (2011).
- B. Isidor, G. Podevin, C. Camby, J.‐F. Mosnier, A. Chauty, J.‐M. Lyet, P. Fergelot, D. Lacombe, B. Arveiler, A. Pelet, J. Amiel and A. David, Rubinstein–Taybi syndrome and Hirschsprung disease in a patient harboring an intragenic deletion of the CREBBP gene, American Journal of Medical Genetics Part A, 152A, 7, (1847-1848), (2010).
- Cristina Gervasini, Federica Mottadelli, Roberto Ciccone, Paola Castronovo, Donatella Milani, Gioacchino Scarano, Maria Francesca Bedeschi, Serena Belli, Alba Pilotta, Angelo Selicorni, Orsetta Zuffardi and Lidia Larizza, High frequency of copy number imbalances in Rubinstein–Taybi patients negative to CREBBP mutational analysis, European Journal of Human Genetics, 18, 7, (768), (2010).
- Cezary Wójcik, Kim Volz, Maria Ranola, Karla Kitch, Tariza Karim, Joseph O'Neil, Jodi Smith and Wilfredo Torres‐Martinez, Rubinstein–Taybi syndrome associated with Chiari type I malformation caused by a large 16p13.3 microdeletion: A contiguous gene syndrome?, American Journal of Medical Genetics Part A, 152A, 2, (479-483), (2010).
- Adriana Doldan, Anupama Chandramouli, Reneé Shanas, Achyut Bhattacharyya, John T. Cunningham, Mark A. Nelson and Jiaqi Shi, Loss of the eukaryotic initiation factor 3f in pancreatic cancer, Molecular Carcinogenesis, 47, 3, (235-244), (2007).
- Adriana Doldan, Anupama Chandramouli, Reneé Shanas, Achyut Bhattacharyya, Stanley P.L. Leong, Mark A. Nelson and Jiaqi Shi, Loss of the eukaryotic initiation factor 3f in melanoma, Molecular Carcinogenesis, 47, 10, (806-813), (2008).
- Hoa T. Truong, Sara Solaymani-Kohal, Kevin R. Baker, Santhosh Girirajan, Stephen R. Williams, Christopher N. Vlangos, Ann C.M. Smith, David J. Bunyan, Paul E. Roffey, Christopher L. Blanchard and Sarah H. Elsea, Diagnosing Smith–Magenis Syndrome and Duplication 17p11.2 Syndrome byRAI1Gene Copy Number Variation Using Quantitative Real-Time PCR, Genetic Testing, 12, 1, (67), (2008).
- J.M. Levenson and M.A. Wood, Epigenetics – Chromatin Structure and Rett Syndrome, Learning and Memory: A Comprehensive Reference, 10.1016/B978-012370509-9.00043-7, (859-878), (2008).
- Ada Ao and Jianrong Lu, Proteins That Alter Histone Modifications in Cancer, Cancer Epigenetics, 10.1201/9781420045802.ch10, (181-195), (2009).
- Asako Koike and Toshihisa Takagi, Knowledge discovery based on an implicit and explicit conceptual network, Journal of the American Society for Information Science and Technology, 58, 1, (51-65), (2006).
- Cristina Gervasini, Paola Castronovo, Angela Bentivegna, Federica Mottadelli, Francesca Faravelli, Maria Luisa Giovannucci-Uzielli, Alice Pessagno, Emanuela Lucci-Cordisco, Anna Maria Pinto, Leonardo Salviati, Angelo Selicorni, Romano Tenconi, Giovanni Neri and Lidia Larizza, High frequency of mosaic CREBBP deletions in Rubinstein–Taybi syndrome patients and mapping of somatic and germ-line breakpoints, Genomics, 90, 5, (567), (2007).
- Nicole Zimmermann, Ana Maria Bravo Ferrer Acosta, Jürgen Kohlhase and Oliver Bartsch, Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndrome, European Journal of Human Genetics, 15, 8, (837), (2007).
- Marianne Stef, Delphine Simon, Béatrice Mardirossian, Marie-Ange Delrue, Ingrid Burgelin, Christophe Hubert, Michèle Marche, Françoise Bonnet, Philippe Gorry, Michel Longy, Didier Lacombe, Isabelle Coupry and Benoît Arveiler, Spectrum of CREBBP gene dosage anomalies in Rubinstein–Taybi Syndrome patients, European Journal of Human Genetics, 15, 8, (843), (2007).
- Marianne Stef, Delphine Simon, Ingrid Burgelin, Isabelle Guisle, Catherine Chevalier, Marie‐Ange Delrue, Didier Lacombe, Jean Léger and Benoît Arveiler, Testing and improving experimental parameters for the use of low molecular weight targets in array‐CGH experiments, Human Mutation, 27, 11, (1143-1150), (2006).
- Oliver Bartsch, Sasan Rasi, Alicia Delicado, Sarah Dyack, Luitgard M. Neumann, Eva Seemanová, Marianne Volleth, Thomas Haaf and Vera M. Kalscheuer, Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein–Taybi syndrome, Human Genetics, 120, 2, (179), (2006).
- Sara C. Shalin, Regula Egli, Shari G. Birnbaum, Tania L. Roth, Jonathan M. Levenson and J. David Sweatt, Signal transduction mechanisms in memory disorders, Reprogramming of the Brain, 10.1016/S0079-6123(06)57003-7, (25-384), (2006).
- Angela Bentivegna, Donatella Milani, Cristina Gervasini, Paola Castronovo, Federica Mottadelli, Stefano Manzini, Patrizia Colapietro, Lucio Giordano, Francesca Atzeri, Maria T Divizia, Maria L Giovannucci Uzielli, Giovanni Neri, Maria F Bedeschi, Francesca Faravelli, Angelo Selicorni and Lidia Larizza, Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients, BMC Medical Genetics, 7, 1, (2006).
- Helena Santos-Rosa and Carlos Caldas, Chromatin modifier enzymes, the histone code and cancer, European Journal of Cancer, 10.1016/j.ejca.2005.08.010, 41, 16, (2381-2402), (2005).
- Oliver Bartsch, Stefanie Schmidt, Marion Richter, Susanne Morlot, Eva Seemanová, Glenis Wiebe and Sasan Rasi, DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS, Human Genetics, 117, 5, (485), (2005).
- Maofu Fu, Chenguang Wang, Mahadev Rao, Xiaofang Wu, Toula Bouras, Xueping Zhang, Zhiping Li, Xuanmao Jiao, Jianguo Yang, Anping Li, Neil D. Perkins, Bayar Thimmapaya, Andrew L. Kung, Alberto Munoz, Antonio Giordano, Michael P. Lisanti and Richard G. Pestell, Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism, Journal of Biological Chemistry, 10.1074/jbc.M503188200, 280, 33, (29728-29742), (2005).
- Han-Tsang Wu, Yi-Chih Kuo, Jung-Jyh Hung, Chi-Hung Huang, Wei-Yi Chen, Teh-Ying Chou, Yeh Chen, Yi-Ju Chen, Yu-Ju Chen, Wei-Chung Cheng, Shu-Chun Teng and Kou-Juey Wu, K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression, Nature Communications, 10.1038/ncomms13644, 7, (13644), (2016).
